Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) EBT (2016 - 2026)

Nutex Health (NUTX) has disclosed EBT for 17 consecutive years, with $76.6 million as the latest value for Q1 2026.

  • For Q1 2026, EBT rose 7.5% year-over-year to $76.6 million; the TTM value through Mar 2026 reached $250.1 million, up 38.04%, while the annual FY2025 figure was $244.8 million, 122.88% up from the prior year.
  • EBT hit $76.6 million in Q1 2026 for Nutex Health, up from $25.9 million in the prior quarter.
  • Across five years, EBT topped out at $123.9 million in Q3 2025 and bottomed at -$431.5 million in Q3 2022.
  • Average EBT over 5 years is -$2.2 million, with a median of -$152000.0 recorded in 2024.
  • Year-over-year, EBT crashed 675.67% in 2022 and then skyrocketed 46952.63% in 2025.
  • Nutex Health's EBT stood at -$8.9 million in 2022, then plummeted by 246.87% to -$30.7 million in 2023, then skyrocketed by 453.81% to $108.7 million in 2024, then plummeted by 76.17% to $25.9 million in 2025, then skyrocketed by 195.67% to $76.6 million in 2026.
  • According to Business Quant data, EBT over the past three periods came in at $76.6 million, $25.9 million, and $123.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.